We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.8%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$665M
AUM Growth
-$2.54M
(-0.38%)
Cap. Flow
-$45.7M
Cap. Flow
% of AUM
-6.88%
Top 10 Holdings %
Top 10 Hldgs %
32.24%
Holding
202
New
60
Increased
44
Reduced
30
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$21.2M |
| 2 |
Marathon Petroleum
MPC
|
+$15.3M |
| 3 |
Alibaba
BABA
|
+$14.3M |
| 4 |
Golar LNG
GLNG
|
+$10.9M |
| 5 |
PENN Entertainment
PENN
|
+$9.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
|
+$43.9M |
| 2 |
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
|
+$21.1M |
| 3 |
CELG
Celgene Corp
CELG
|
+$18.2M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$11.6M |
| 5 |
Ashland
ASH
|
+$9.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.5% |
| 2 | Technology | 21.05% |
| 3 | Industrials | 7.74% |
| 4 | Energy | 6.85% |
| 5 | Utilities | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAC
126
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $364K | 0.05% |
68,000
-28,200
| -29% | -$154K |
|
127
ADMA Biologics
ADMA
$2.04B
| $361K | 0.05% |
+80,000
| New | +$399K |
|
128
Aldeyra Therapeutics
ALDX
$95.3M
| $358K | 0.05% |
45,000
| – | – |
|
|
APEN
129
DELISTED
Apollo Endosurgery, Inc.
APEN
| $349K | 0.05% |
50,000
+10,000
| +25% | +$62.2K |
|
130
Karyopharm Therapeutics
KPTI
$161M
| $348K | 0.05% |
+1,367
| New | +$338K |
|
131
Lamb Weston
LW
$7.51B
| $342K | 0.05% |
+5,000
| New | +$327K |
|
132
Roku
ROKU
$21.3B
| $341K | 0.05% |
+8,000
| New | +$292K |
|
133
Viking Therapeutics
VKTX
$3.93B
| $332K | 0.05% |
+35,000
| New | +$233K |
|
134
Boston Scientific
BSX
$68.5B
| $327K | 0.05% |
10,000
-10,000
| -50% | -$302K |
|
|
EIGR
135
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $305K | 0.05% |
+833
| New | +$297K |
|
136
Arrowhead Research
ARWR
$12.1B
| $272K | 0.04% |
20,000
| – | – |
|
137
Lennar Class A
LEN
$21.1B
| $263K | 0.04% |
+5,165
| New | +$270K |
|
138
Interactive Brokers
IBKR
$40.5B
| $258K | 0.04% |
+16,000
| New | +$290K |
|
139
Spotify
SPOT
$105B
| $252K | 0.04% |
+1,500
| New | +$240K |
|
140
Harrow
HROW
$1.47B
| $220K | 0.03% |
100,000
+30,000
| +43% | +$67K |
|
141
Option Care Health
OPCH
$3.53B
| $220K | 0.03% |
18,750
-6,250
| -25% | -$65.5K |
|
142
Coherus Oncology
CHRS
$222M
| $210K | 0.03% |
15,000
-15,000
| -50% | -$215K |
|
143
Arcadia Biosciences
RKDA
$1.37M
| $206K | 0.03% |
+626
| New | +$342K |
|
144
Philip Morris
PM
$312B
| $202K | 0.03% |
+2,500
| New | +$212K |
|
|
AIMT
145
DELISTED
Aimmune Therapeutics
AIMT
| $202K | 0.03% |
+7,500
| New | +$230K |
|
|
BBBY
146
DELISTED
Bed Bath & Beyond Inc
BBBY
| $199K | 0.03% |
+10,000
| New | +$187K |
|
|
LITS
147
Lite Strategy Inc
LITS
$33M
| $197K | 0.03% |
+2,500
| New | +$153K |
|
148
Rocket Pharmaceuticals
RCKT
$343M
| $196K | 0.03% |
10,000
-5,000
| -33% | -$94.6K |
|
|
VTNR
149
DELISTED
Vertex Energy, Inc
VTNR
| $175K | 0.03% |
+165,413
| New | +$181K |
|
|
ASXC
150
DELISTED
Asensus Surgical, Inc.
ASXC
| $109K | 0.02% |
+1,923
| New | +$70K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Ardsley Advisory Partners held 202 positions worth $665M, down 0.38% from $667M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ardsley Advisory Partners withdrew a net $45.7M in Q2 2018, closing 52 positions and reducing 30 holdings. Its most notable exit was ProShares Trust UltraShort Lehman 20+ Year Treasury, an estimated $43.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
Against the trend, Ardsley Advisory Partners opened a new position in Baidu worth $20.7M.
- Ardsley Advisory Partners's largest Q2 2018 buy was Baidu: 85,000 shares worth $20.7M.
- Ardsley Advisory Partners added most to Golar LNG in Q2 2018, an estimated $10.9M increase.
- Ardsley Advisory Partners's biggest Q2 2018 reduction was Atlantica Sustainable Infrastructure plc Ordinary Shares, cutting an estimated $21.1M.
- Ardsley Advisory Partners fully exited ProShares Trust UltraShort Lehman 20+ Year Treasury in Q2 2018, selling an estimated $43.9M.
- Ardsley Advisory Partners's ten largest holdings make up 32% of its $665M portfolio in Q2 2018.
- Ardsley Advisory Partners opened 60 new positions and closed 52 in Q2 2018.
- Ardsley Advisory Partners's portfolio value fell 0.38% quarter-over-quarter to $665M.
Based on Ardsley Advisory Partners's 13F filing for Q2 2018, filed 14 Aug 2018.